Peri-anal disease: do surgeons ever make a difference?
Presented by Alessandro Fichera, MD at the SAGES 2013 Annual Meeting; SAGES/ISLCRS Panel: IBD outline–52 sec epidemiology–1:19 https://www.ncbi.nlm.nih.gov/pubmed/11910338 https://www.ncbi.nlm.nih.gov/pubmed/7429313 classification–2:59 https://www.ncbi.n Keyword(s): abscesses, ABX, ACCENT 1 trial, adalimumab, adipose-derived stem cells, advancement flap, algorithm, anal canal, anal fistulae, anal fistulas, Annals of Internal Medicine, anorectal complications, anorectal fistulae, anti-TNF alpha local therapy, anti-TNF antibodies, antibody, […]
Criteria for surgical decision-making: biologics, age, nutrition, desire for pregnancy….
Presented by Elizabeth Collens Wick, MD at the SAGES 2013 Annual Meeting; SAGES/ISLCRS Panel: IBD objectives–10 sec CD overview–28 sec surgery for CD–1:10 perf-disease: intra-abdominal abscess–2:05 perf-disease: fistulas–3:11 non-perf: strictures–3:55 endoscopic balloon dilation–4:34 Keyword(s): 5-ASA derivatives, abdominal pain, ABX, active disease, adverse events, AJG, algorithm, anastomotic leak, APT, azathioprine, biologics, bladder, bowel, bowel preservation, bowel […]